Volatility in the global equity market continued last week, as consumer confidence and tightening monetary policy continued to slow down growth.
Last week the FTSE 100 finished the week up slightly, after it was revealed the UK’s GDP rose by 0.8% in Q1 2022.
This was slightly below the Bank of England’s forecasts of 0.9%. The trend over the quarter was downward, with 0.7% growth in January, 0% growth in February, and a 0.1% contraction in March.
Economists were generally gloomy about the outlook for the rest of the year in the UK. Modupe Adegbembo, economist at AXA Investment Managers, said: “Growth is likely to remain subdued in the coming months as consumers grapple with rising energy prices and tax increases, which policy is doing little to offset. Savings will play some part in supporting consumption, but there is large uncertainty about where these reserves lie and how they will be used by households.”
George Brown, economist at Schroders, said he expected the economy to contract over the second quarter thanks to capacity constraints, low consumer confidence, the increasing income squeeze and a ‘sharp contraction’ in June on account of the Queen’s Jubilee bank holiday weekend.
Looking beyond the second quarter, he noted: “We suspect the UK will avoid falling into a technical recession (two consecutive quarters of negative growth). Contractions incurred by the Jubilee celebrations in 2002 and 2012 were followed by sharp July rebounds. We think history will repeat itself and ensure that GDP grows over the third quarter as a whole. Beyond this, we think that the economy could head back into reverse in the fourth quarter as the Ofgem price cap rises by a further 40% or so. A key factor will be what additional support the Chancellor provides and whether this comes in the autumn Budget or if he bows to pressure for an emergency fiscal package.”
Inflation data in the UK is due to be released this week, with the headline rate expected to have increased again, this time to 9.1%, its highest rate in over 30 years. Unemployment, which is forecast to have held steady at 3.8% last month and retail sales are also due this week.
In the US, equities continued to fall last week as concerns regarding the economic outlook continued to impact investor sentiment. With the Federal Reserve committed to hiking rates quickly amid spiking inflation, expectations of a soft landing (where an economy shifts from higher growth to lower growth but avoids a recession) for the US have deteriorated. The S&P 500 fell by 2.4%, the sixth consecutive week that it has declined.
The fall came despite relatively strong earnings from companies in the index. According to Capital Economics, of the approximately 90% of companies that have so far reported their results, around three quarters have beaten expectations, and aggregate earnings for companies in the S&P 500 are forecast to grow by roughly 10% in 2022 and 2023.
Rising interest rates are overshadowing positive results and driving the market downturn. “This may mean there is a silver lining for equities,” suggested Thomas Mathews, markets economist at Capital Economics. He said the S&P 500 has often rebounded more quickly when monetary policy is the reason for the fall compared to earnings-driven falls.
There was a brighter picture in the EU, where a strong second half of the week saw the DAX in Germany ultimately closing +2.6%. Overall, the MSCI Europe Ex UK was up 0.57%.
However, these headline rates hide persistent volatility across the continent, as economies grapple with the ramifications of the ongoing war in Ukraine, as well as fears of the effects of China’s zero-Covid strategy.
This all highlights the importance of long-term thinking for investors. While it be uncomfortable to see markets swing up and down, it’s important to remember that reacting to the news cycle can jeopardise your long-term strategy. By remaining invested in a diverse portfolio that is matched to your level of risk and spread across different asset classes, and speaking with your Partner about the volatility, you can navigate the headlines with greater confidence.
If you need long-term care, it’s likely to be an expensive business – even more so if you’re one of the 850,0001 people in the UK suffering from some form of dementia.
How much does dementia care cost?
The average annual cost for nursing care in the UK is £50,0002, although it varies according to where you live. That’s almost 40% more than standard residential care.
Who pays for dementia care?
Many people in the UK believe that if you’re suffering from dementia, the costs of care will be met by the NHS because it’s an illness. However, dementia sufferers often have to pay care home fees themselves.
In order to qualify for Continuing Healthcare (CHC), where the NHS will pay for some or all of your care, you need to have a “primary medical need”, explains Ros Clarke, Long-Term Care Consultant at St. James’s Place (and note also that CHC doesn’t apply in Scotland).
“Qualifying for CHC is very tricky, and most dementia sufferers will not be considered eligible” she says. “Although a medical condition, the care needs of people with Alzheimer’s are often considered to be ‘social care needs’ and people who are suffering from it often don’t meet the necessary criteria.”
“It’s also important to remember that CHC isn’t means-tested,” says Ros. “If you’re eligible, you’ll receive funding regardless of your financial circumstances.”
If you’re not sure whether you or a loved one might qualify for CHC, Ros recommends contacting Beacon, an organisation that will give you a free consultation to assess your eligibility and offer guidance on whether it’s worth challenging a decision that has gone against you.
The time to act is now
“Start having conversations about this as early as possible in your financial journey, so you can put some planning in place for this potentially happening to you.”
Ros advises setting up a power of attorney so a trusted person can make decisions on your behalf if you’re no longer able to.
“Without one in place, being able to do anything for a person with dementia is a minefield, even if you’re their next of kin,” she says. “Your powers to manage their finances or make healthcare decisions for them are severely limited. But with one in place, you can ensure that important decisions can be made quickly. And, again, act now before it’s too late – once someone has dementia, it’s no longer possible to set one up as they may not understand what they’re agreeing to.”
Powers of Attorney involve the referral to a service that is separate and distinct to those offered by St. James’s Place and are not regulated by the Financial Conduct Authority.
1 Dementia, NHS, accessed April 2022
2 Laing and Buisson Care Homes for Older People, 2022
The Last Word
“For us, it’s not just a victory in Eurovision of course, it’s more than that, we saw full support from all European countries. We received highest points from 40 countries.”
Ukrainian TV presenter and Eurovision commentator Timur Miroshnychenko on what his country’s victory at Eurovision meant
AXA Investment Managers and Schroders are fund managers for St. James’s Place.
The information contained is correct as at the date of the article. The information contained does not constitute investment advice and is not intended to state, indicate or imply that current or past results are indicative of future results or expectations. Where the opinions of third parties are offered, these may not necessarily reflect those of St. James’s Place.
Source: London Stock Exchange Group plc and its group undertakings (collectively, the “LSE Group”). ©LSE Group 2022. FTSE Russell is a trading name of certain of the LSE Group companies.
“FTSE Russell®” is a trade mark of the relevant LSE Group companies and is used by any other LSE Group company under license. All rights in the FTSE Russell indexes or data vest in the relevant LSE Group company which owns the index or the data. Neither LSE Group nor its licensors accept any liability for any errors or omissions in the indexes or data and no party may rely on any indexes or data contained in this communication. No further distribution of data from the LSE Group is permitted without the relevant LSE Group company’s express written consent. The LSE Group does not promote, sponsor or endorse the content of this communication.
© S&P Dow Jones LLC 2022; all rights reserved
Source: MSCI. MSCI makes no express or implied warranties or representations and shall have no liability whatsoever with respect to any MSCI data contained herein. The MSCI data may not be further redistributed or used as a basis for other indices or any securities or financial products. This report is not approved, endorsed, reviewed or produced by MSCI. None of the MSCI data is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such.